Chameleon 发表于 2025-3-23 11:54:01
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estr) and the absence of type-2 epidermal growth factor receptor (HER-2) overexpression. This status makes TNBC a challenge for scientists and physicians. Many studies tried to characterize the TNBC to find new targetable proteins to cure this BC subgroup, and the results have certainly underlined its hLITHE 发表于 2025-3-23 15:53:54
http://reply.papertrans.cn/20/1928/192759/192759_12.pngILEUM 发表于 2025-3-23 19:27:20
http://reply.papertrans.cn/20/1928/192759/192759_13.pngTremor 发表于 2025-3-24 01:33:30
Tumor Microenvironment Modulation and Its Impact on Immunotherapy in Triple-Negative Breast Cancer,se due to the lack of specific targetable receptors and its extremely invasive nature makes it a significant point of scientific interest. The tumor microenvironment (TME) in TNBC is a dynamic and diverse landscape composed of various cellular components involving immune cells (macrophages, dendritiFerritin 发表于 2025-3-24 03:39:29
http://reply.papertrans.cn/20/1928/192759/192759_15.png中古 发表于 2025-3-24 09:09:56
http://reply.papertrans.cn/20/1928/192759/192759_16.pngjudiciousness 发表于 2025-3-24 11:34:32
http://reply.papertrans.cn/20/1928/192759/192759_17.pngadipose-tissue 发表于 2025-3-24 18:45:15
http://reply.papertrans.cn/20/1928/192759/192759_18.pngPerennial长期的 发表于 2025-3-24 22:56:56
http://reply.papertrans.cn/20/1928/192759/192759_19.png压倒 发表于 2025-3-25 01:10:44
Konstruktion von Vorhersagekarten,d therapy for TNBC is challenging. Chemotherapy, radiation therapy, and surgical resection are the existing treatment options for TNBC. Chemotherapy is sensitive to TNBC; however, development of resistance mechanisms and recurrence remain the major reasons of treatment failure in patient with TNBC.